Updated Dec. 5, 2013 at 6:53 a.m.

Premium Lock Raleigh startup FLAG Therapeutics lands exclusive rights to Duquesne cancer compounds

Published: 2013-12-05 06:53:00
Updated: 2013-12-05 06:53:48

FLAG Therapeutics FLAG Therapeutics

The experimental cancer drugs FLAG Therapeutics licensed from Duquesne University could offer safer and more targeted cancer treatment compared to existing cancer drugs, says the new drug firm FLAG Therapeutics....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders